Cargando…
Knockdown of CDCA5 suppresses malignant progression of breast cancer cells by regulating PDS5A
Breast cancer is one of the most common malignant tumors in women. Cell division cycle-associated 5 (CDCA5) is closely associated with the behavior of various cancer types. The aim of the present study was to explore the effect of CDCA5 on breast cancer. Western blot analysis and reverse transcripti...
Autores principales: | Wang, Yang, Yao, Jian, Zhu, Yulin, Zhao, Xuejiao, Lv, Jing, Sun, Fulan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133959/ https://www.ncbi.nlm.nih.gov/pubmed/35506437 http://dx.doi.org/10.3892/mmr.2022.12725 |
Ejemplares similares
-
PDS5A and PDS5B in Cohesin Function and Human Disease
por: Zhang, Nenggang, et al.
Publicado: (2021) -
Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018) -
CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022) -
SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway
por: Luo, Zhenzhen, et al.
Publicado: (2021) -
Pds5A and Pds5B Display Non-redundant Functions in Mitosis and Their Loss Triggers Chk1 Activation
por: Al-Jomah, Naif, et al.
Publicado: (2020)